Objective-To compare expression of the p75 chain of the interleukin-2 receptor (IL-2Rp75, CD122) on peripheral and synovial mononuclear cells in rheumatoid and non-rheumatoid inflammatory arthritis. Methods-Peripheral blood (PBMC) and synovial (SFMC) mononuclear cells were isolated from subjects with rheumatoid arthritis (n = 16) and non-rheumatoid inflammatory arthritis (n = 12). PBMC were isolated from six healthy controls. Expression of CD122 was examined using indirect immunofluorescence and quantitative flow cytometry. Results-There was no difference in IL-2Rp75 expression on PBMC from rheumatoid arthritis patients, nonrheumatoid arthritis patients, and controls. In subjects with rheumatoid arthritis there was no difference in IL-2Rp75 expression on PBMC and SFMC. However, in the non-rheumatoid arthritis group there was an increase in IL-2Rp75 expression on SFMC compared with PBMC (P = 0.0032). On SFMC there was a greater expression of IL-2Rp75 in non-rheumatoid arthritis than in rheumatoid arthritis (P = 0.0007). Expression was greater on CD8 positive cells and in subjects with shorter duration of disease. Conclusions-The p75 chain of the IL-2 receptor, an important T cell activation antigen, is not upregulated in synovial fluid. This appears to be a disease specific defect and provides further support for the concept of "frustrated" or incomplete T cell activation in this disease.
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The role of T cells in rheumatoid synovitis remains controversial. The most widely accepted model proposes presentation of an "arthritogenic peptide" in the context of certain HLA class II specificities, resulting in expansion of antigen specific T cells, production of T cell derived cytokines, and a chronic inflammatory destructive synovitis. This view is supported by a number of observations and has been reviewed elsewhere,' though the degree to which it is responsible for established synovitis has been challenged.2
The most potent stimulus to T cell expansion is interleukin-2 (IL-2). The high affinity IL-2 receptor (IL-2R) is formed by a complex between at least three molecules including the p55 chain (CD25), the p75 chain (IL-2Rp75, CD122), and the recently identified third subunit, the y chain. Despite the presence of other activation markers, only a minority of synovial fluid mononuclear cells are positive for IL-2R, at least when measured using an antibody directed against the IL-2Rp55 chain.' This, combined with findings of defective IL-2 secretion in rheumatoid arthritis and hyporesponsiveness of rheumatoid arthritis synovial fluid cells to mitogenic stimuli,4 has given rise to the concept of "frustrated activation" of synovial fluid T cells.'
The larger p75 subunit has not been studied in rheumatoid arthritis, though the fact that some cells do not express IL-2Rp55' yet are capable of responding to IL-26 and that IL-2Rp75 contains the functional domain for signal transduction6 suggests that it may be of importance.
IL-2 is known to stimulate resting T cells to produce y interferon in the absence of antigen and without a proliferative response.7 This effect is almost certainly mediated through the p75 receptor. T cells from rheumatoid arthritis patients fail to produce normal levels of y interferon in response to IL-2' though they respond normally to allogeneic cells, suggesting that the responsiveness to IL-2 rather than the synthetic capacity for y interferon is reduced in rheumatoid arthritis. One explanation of this defect, which appears to be disease specific, would be downregulation of IL-2 receptors.
The aim of this study was to test the hypothesis that IL-2Rp75 is specifically downregulated in rheumatoid arthritis. This was done by quantitating expression of IL2Rp75 on peripheral mononuclear cells (PBMC) and synovial fluid mononuclear cells (SFMC) using flow cytometry.
Methods

SUBJECTS
Blood and synovial fluid was obtained from knee joints of outpatients (n = 28) who required arthrocentesis for therapeutic purposes. Sixteen subjects had rheumatoid arthritis and 12 had joint disease other than rheumatoid arthritis: psoriatic arthritis (n = 2), seronegative spondarthropathy (n = 5), calcium pyrophosphate disease (n = 2), osteoarthritis (n = 1), post-traumatic (n = 1) and post-streptococcal arthritis (n = 1). The results were also analysed to examine the effect of disease duration (less than or more than three years) on expression of IL-2Rp75 (see table 2 ). The two groups were well matched in terms of plasma viscosity, C reactive protein level, articular index, and duration of early morning stiffness, but there was a greater expression of IL-2Rp75 in subjects with recent disease, significantly so in the case of PBMC. No correlation was seen between IL-2Rp75 levels and pain, plasma viscocity, C reactive protein, articular index, or duration of early morning stiffness. Expression of IL2R p75 on PBMC correlated with expression on SFMC (r = 0.44, P = 0.02).
Discussion
We have re-examined IL-2R expression using antibody to the p75 chain and methodology which permits quantitation of receptor numbers. The methodology-like other methods of deriving antigen binding sites-make The impaired function of synovial T cells, as represented by a relative reduction in IL-2Rp75 expression, could result in failure to regulate proinflammatory functions of non-T cells in the joint, leading to uncontrolled, cytokine driven, chronic inflammation with the clinical and pathological sequelae seen in established rheumatoid arthritis.
